Opexa Therapeutics (OPXA +3.2%) trades up today after signing a sales agreement with Brinson Patrick Securities, under which the company may sell shares of its common stock, with Brinson Patrick Securities as its sales agent on a 3% commission.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs